Carbapenem-resistant enterobacteriaceae in pediatric patients: Epidemiology and risk factors

Infection Control and Hospital Epidemiology

Volumn 35, Issue 4, 2014, Pages 447-449

  Dirajlal Fargo, Sahera ^a,b   DeBiasi, Roberta ^a,b   Campos, Joseph ^a,b   Song, Xiaoyan ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CEPHALOSPORIN; COTRIMOXAZOLE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ADOLESCENT; ADULT; BACTERIAL COLONIZATION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; FEMALE; INFANT; KLEBSIELLA PNEUMONIAE; MALE; NOTE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; EPIDEMIOLOGY; GROWTH, DEVELOPMENT AND AGING; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; RISK; UNITED STATES;

ADOLESCENT; CARBAPENEMS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DISTRICT OF COLUMBIA; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INFANT; MALE; ODDS RATIO; RISK FACTORS;

EID: 84895812767     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/675593     Document Type: Note

References (10)

1. Bratu S, Landman D, Alam M, Tolentino E, Quale J. Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York. Antimicrob Agents Chemother 2005; 49:776-778.
2. Cuzon G, Naas T, Truong H, et al. Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene. Emerg Infect Dis 2010;16:1349-1356.
3. Patel N, Harrington S, Dihmess A, et al. Clinical epidemiology of carbapenem-intermediate or-resistant Enterobacteriaceae. J Antimicrob Chemother 2011;66:1600-1608.
4. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008;52:1028-1033.
5. Logan LK. Carbapenem-resistant Enterobacteriaceae: an emerging problem in children. Clin Infect Dis 2012;55:852-859.
6. Limbago BM, Rasheed JK, Anderson KF, et al. IMP-producing carbapenem-resistant Klebsiella pneumoniae in the United States. J Clin Microbiol 2011;49:4239-4245.
7. Little ML, Qin X, Zerr DM, Weissman SJ. Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobacteriaceae. Int J Antimicrob Agents 2012;39:52-57.
8. Oteo J, Hernandez-Almaraz JL, Gil-Anton J, et al. Outbreak of vim-1-carbapenemase-producing Enterobacter cloacae in a pediatric intensive care unit. Pediatr Infect Dis J 2010;29:1144-1146.
9. Centers for Disease Control and Prevention (CDC). 2012 CRE toolkit: Guidance for Control of Carbapenem Resistant Enterobacteriaceae. Atlanta, GA: CDC, 2012.
10. Marchaim D, Chopra T, Perez F, et al. Outcomes and genetic relatedness of carbapenem-resistant Enterobacteriaceae at Detroit medical center. Infect Control Hosp Epidemiol 2011;32:861-871.